2 news items
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
MRVI
13 May 24
and access to TriLink's proprietary in vitro transcription technology, CleanScript™, which will enable Hopkins researchers to advance mRNA
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
BREA
CELZ
DIS
8 Mar 24
). In a press release, Creative Medical Technology Holdings announced that it had received FDA authorization for an expanded-access therapy featuring CELZ 201
- Prev
- 1
- Next